Vogt-Koyanagi-Harada Disease in a Pregnant Patient Successfully Treated with Intravitreal Triamcinolone Injection.
10.3341/jkos.2013.54.10.1621
- Author:
Hyun Duck KWAK
1
;
Sung Hyup LIM
;
Hyung Woong KIM
;
Il Han YUN
;
Ho Young LEE
Author Information
1. Department of Ophthalmology, Busan Paik Hospital, Inje University College of Medicine, Busan, Korea. happytriad@gmail.com
- Publication Type:Case Report
- Keywords:
Intravitreal triamcinolone injection;
Pregnancy;
Vogt-Koyanagi-Harada disease
- MeSH:
Anterior Chamber;
Eye;
Female;
Follow-Up Studies;
Headache;
Humans;
Infant;
Infant, Low Birth Weight;
Infant, Newborn;
Inflammation;
Ophthalmic Solutions;
Prednisolone;
Pregnancy;
Pregnant Women;
Retinal Detachment;
Tinnitus;
Triamcinolone*;
Uveomeningoencephalitic Syndrome*;
Vision, Ocular;
Visual Acuity;
Young Adult
- From:Journal of the Korean Ophthalmological Society
2013;54(10):1621-1625
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
PURPOSE: To report a case of Vogt-Koyanagi-Harada (VKH) disease in a pregnant patient treated with intravitreal triamcinolone injection. CASE SUMMARY: A 21-year-old female in the 19th week of gestation presented with bilateral blurring of vision associated with mild headache and tinnitus. Her initial best corrected visual acuity was 0.15 in the right eye and 0.3 in the left eye. Multiple serous retinal detachment and anterior chamber inflammation were observed, and VKH disease was diagnosed. Because of her pregnancy, the patient did not want high-dose systemic prednisolone therapy which may cause an abortion or low birth weight infant when used in a pregnant patient. Therefore, an intravitreal triamcinolone (4 mg/0.1 ml) injection was given in the right eye and topical steroid eye drops were used in the left eye. After 1 day, serous retinal detachment was significantly decreased and anterior chamber inflammation disappeared in the right eye. After 1 week, no serous retinal detachment was observed. In the left eye, serous retinal detachment was decreased after using steroid eye drops. After 10 days, serous retinal detachment disappeared but anterior chamber inflammation was still observed. After 1 month, best corrected visual acuity was 1.0 in both eyes and serous retinal detachment had not recurred. On follow-up, VKH disease had not recurred and a healthy normal weight infant was delivered. CONCLUSIONS: Intravitreal triamcinolone injection is an effective and safe treatment for VKH disease in pregnant women.
